THURSDAY, Feb. 3, 2022 (HealthDay News) — Alan Holman didn’t stop exercising when told he had cancer, and he’s glad of it, now that U.K. researchers say moderate exercise may improve chemotherapy outcomes in esophageal cancer patients. Holman, 70, was diagnosed with esophageal cancer in December 2016, shortly after retiringContinue Reading

WEDNESDAY, Feb. 2, 2022 (HealthDay News) — Pap tests have long been used to detect cervical cancer early, but preliminary research suggests that cervical cells collected during those tests could also be used to catch other cancers, including deadly ovarian tumors. Researchers found that by analyzing a particular molecular “signature”Continue Reading

WEDNESDAY, Feb. 2, 2022 (HealthDay News) — Four in 10 Americans say they’ve had at least one heart-related issue during the COVID-19 pandemic, and about one in four who have tested positive say COVID has affected their heart health, according to a new online poll. Shortness of breath (18%), dizzinessContinue Reading

WEDNESDAY, Feb. 2, 2022 (HealthDay News) — Many American teens and young adults underestimate the risk of sexually transmitted infections from unprotected oral sex, and that’s especially true of young men, a new survey shows. Doctors say oral sex can transmit herpes, gonorrhea, chlamydia, syphilis, HIV and human papillomavirus (HPV),Continue Reading

TUESDAY, Feb. 1, 2022 (HealthDay News) — Colon cancer rates are increasing for younger Americans, along with rates of obesity. Could slimming down reduce young people’s risk for malignancy? A new study suggests that even a small amount of weight loss may cut your odds for benign growths in theContinue Reading

FRIDAY, Jan. 28, 2022 (HealthDay News) — When delivering a liver cancer diagnosis, Dr. Thomas Marron pulls no punches: “Liver cancer is one of the deadliest cancers,” he tells patients. Jeffrey Foster heard a similar message loud and clear when he was first diagnosed by another doctor with hepatocellular carcinomaContinue Reading

THURSDAY, Jan. 27, 2022 (HealthDay News) — Most gene variants that have been labeled “pathogenic” may make only a small difference in a person’s risk of actually developing disease, a new study suggests. Scouring genetic data on more than 72,000 individuals, researchers found that most of the gene variants believedContinue Reading

THURSDAY, Jan. 27, 2022 (HealthDay News) — Finding the right medication for rheumatoid arthritis isn’t easy, and a newer pill against the disease carries higher risks of heart attack, stroke and cancer than older RA drugs, a new clinical trial confirms. The study was mandated by the U.S. Food andContinue Reading